Indiscriminate use resulted in fake tocilizumab injections for COVID treatment: FDCA Ruchika Sharma20 July 2020 10:30 AM ISTTaking advantage of this demand-supply gap, some people tried to make spurious tocilizumab injections under a fake pharma company, called Genic...
Cipla gets USFDA nod to generic version of Firazyr Ruchika Sharma14 July 2020 11:52 AM ISTIcatibant injection is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.
DoP junks Cipla plea against NPPA for price fixation of Synchrobreathe Inhaler Farhat Nasim12 July 2020 3:00 PM ISTNew Delhi: In a setback to drugmaker Cipla Ltd., the Department of Pharmaceuticals (DoP) has rejected its review petition filed against...
Cipla launches Cipremi at Rs 4,000 per vial Ruchika Sharma9 July 2020 12:07 PM IST"We are proud to commercially launch Cipremi today (on Wednesday); amongst the lowest priced globally, and aim to supply over 80,000 vials within the...
COVID-19: Sovereign Pharma dispatches first batch of generic remdesivir to Cipla Ruchika Sharma8 July 2020 1:15 PM ISTAt current capacity, the Sovereign can supply 50,000 to 95,000 vials per month of the injectable, the company said in an emailed statement on Tuesday.
Cipla, Boehringer Ingelheim to co-market oral anti-diabetic drugs Oboravo, Oboravo Met, Tiptengio Ruchika Sharma30 Jun 2020 11:28 AM ISTThe Indian diabetes market is valued at INR 1,45,451 million and is growing at 10.35% (IMS MAT May 2020) with the oral anti-diabetic market being...
Cipla to knock out Hetero Healthcare in pricing battle of Remdesivir? Farhat Nasim29 Jun 2020 5:13 PM ISTNew Delhi: Igniting drug pricing battle among pharmaceutical majors, Drug major, Cipla Ltd., has priced antiviral drug Remdesivir at under Rs...
Indian Pharma Industries likely to continue Chinese imports till feasible alternatives emerge Ruchika Sharma28 Jun 2020 9:15 AM ISTHe, however, added that the government has addressed the need to reduce import dependence by bringing in the bulk drug and medical devices policy.
Covid-19 Drug: Cipla to price generic version of Remdesivir at less than Rs 5000 Ruchika Sharma24 Jun 2020 11:55 AM ISTHetero expects to price a similar 100 milligram dose of the treatment at 5,000 to 6,000 rupees.
COVID-19: Cipla launches remdesivir under brand name Cipremi in India Ruchika Sharma22 Jun 2020 4:17 PM ISTCipla has been granted regulatory approval by the Drug Controller General of India (DCGI) for restricted emergency use in the country as part of the...
Cipla, Hetero Labs secure DCGI nod for Remdesivir to treat COVID cases Ruchika Sharma22 Jun 2020 11:01 AM ISTThe drug, administered in the form of injection, should be given at a dose of 200 mg on day one followed by 100 mg daily for five days.
Roche, Cipla collaborate for key oncology drugs Ruchika Sharma19 Jun 2020 12:00 PM ISTUnder this agreement, Cipla will be responsible for marketing and distribution of Roche Pharma's key trademark oncology drugs viz.,Trastuzumab...
